Corporate News

Director/PDMR Shareholding

27 January 2023

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 26 January 2023 it received notification that Jag Grewal, Chief Executive Officer, and Chris Lea, Chief Financial Officer, had each purchased 1,000,000 ordinary shares of 4 pence each in the Company (“Ordinary Shares”), at a price of 3.4839 pence each.

A summary of each Directors resultant holdings is below:

Director	Board Position	Existing number of Ordinary Shares	Ordinary Shares Purchased	Total beneficial holding of Ordinary Shares following these acquisitions

				Number of Ordinary Shares	Approximate % of Company’s issued share capital
Jag Grewal	CEO	1,025,834	1,000,000	2,025,834	0.85%
Chris Lea	CFO	1,030,908	1,000,000	2,030,908	0.85%

Contacts:

Omega Diagnostics Group PLC	www.omegadx.com
Jag Grewal Chief Executive Officer	via Walbrook PR
Chris Lea, Chief Financial Officer

finnCap Ltd	Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
Alice Lane/ Charlotte Sutcliffe (ECM)

Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893
Lianne Applegarth	Mob: 07584 391 303
Sam Allen	Mob: 07502 558 258

About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
www.omegadx.com

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jag Grewal

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial
notification
/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Omega Diagnostics Group PLC

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type
of instrument

Identification
code

Ordinary Shares of 4 pence each

ISIN: GB00B1VCP282

b)

Nature of the
transaction

Ordinary Shares purchased

c)

Price(s) and
volume(s)

Price(s)	Volume(s)
3.4839 pence	1,000,000

d)

Aggregated
information

-Aggregated
volume

See above

- Price

e)

Date of the
transaction

26.01.2023

f)

Place of the
transaction

London Stock Exchange

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris Lea

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial
notification
/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Omega Diagnostics Group PLC

b)

LEI

2138007U9P4BTZTYIR92

4

Details of the tra nsaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type
of instrument

Identification
code

Ordinary Shares of 4 pence each

ISIN: GB00B1VCP282

b)

Nature of the
transaction

Ordinary Shares purchased

c)

Price(s) and
volume(s)